-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, XeQkjzIVvkeqIjgEKZM8jq6kn4CB705/TZblaE8yiZGGV9wwhxtr+imbJWtvtHdC avaFVtYwjfafEYYP1BAkMg== 0000051396-95-000007.txt : 19950601 0000051396-95-000007.hdr.sgml : 19950601 ACCESSION NUMBER: 0000051396-95-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19950217 ITEM INFORMATION: Other events FILED AS OF DATE: 19950301 SROS: MSE SROS: NYSE SROS: PSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: MALLINCKRODT GROUP INC CENTRAL INDEX KEY: 0000051396 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 361263901 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-00483 FILM NUMBER: 95517450 BUSINESS ADDRESS: STREET 1: 7733 FORSYTH BOULEVARD CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 314-854-5299 MAIL ADDRESS: STREET 1: 7733 FORSYTH BLVD CITY: ST. LOUIS STATE: MO ZIP: 63105-1820 FORMER COMPANY: FORMER CONFORMED NAME: IMCERA GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: INTERNATIONAL MINERALS & CHEMICAL CORP DATE OF NAME CHANGE: 19900614 8-K 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 17, 1995 Mallinckrodt Group Inc. (Exact name of registrant as specified in its charter) New York 1-483 36-1263901 (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 7733 Forsyth Boulevard, St. Louis, MO 63105-1820 (Address of principal executive offices) (ZIP Code) Registrant's telephone number, (314)854-5200 including area code Item 5. Other Events A press release was issued February 17, 1995. The relevant portion of the text of that release was as follows: MALLINCKRODT GROUP UNIT COMPLETES PURCHASE OF J.T. BAKER ST. LOUIS, Mo., February 17, 1995 -- Mallinckrodt Group, Inc. (NYSE:MKG) announced today that it has completed the acquisition of J.T. Baker Inc., a manufacturer of laboratory, process and microelectronic chemicals, from Richardson-Vicks, Inc., a subsidiary of The Procter & Gamble Company. An agreement to purchase J.T. Baker was signed on December 15, 1994 with completion of the transaction contingent upon receiving normal governmental approval. The cash-for-stock and debt-assumption transaction, totaling $100 million, covers all of J.T. Baker's worldwide operations. Modest earnings dilution resulting from acquisition accounting adjustments is expected in the second half of the current fiscal year ending June 30, 1995. "We're delighted to implement yet another component of our strategy to build a premier specialty chemicals business through product development, acquisitions, and strategic alliances," said C. Ray Holman, Mallinckrodt Group chairman, president and chief executive officer. "The addition of J.T. Baker's approximately $140 million in annual sales will nearly double the size of Mallinckrodt Chemical Company's Performance and Laboratory Chemicals Division and allow us to strengthen our business by leveraging technology and enhancing our global business platform," said Mack G. Nichols, Mallinckrodt Chemical president and chief executive officer. Founded in 1904, J.T. Baker became a subsidiary of Richardson-Vicks, Inc. in 1941. Richardson-Vicks was purchased by Procter & Gamble in 1985. Procter & Gamble had previously cited the lack of strategic fit between J.T. Baker's chemical business and Procter & Gamble's consumer products focus as the reason for the sale. Mallinckrodt Chemical, founded in St. Louis in 1867, is headquartered in Chesterfield, Mo. Its product lines include analgesics, medicinal narcotics, peptides, catalysts, and laboratory chemicals. Mallinckrodt Chemical is the world's leading producer of acetaminophen, the analgesic used in a number of over-the-counter pain relievers, and is a joint venture partner in a worldwide flavors business. Mallinckrodt Group Inc., a St. Louis-based Fortune 250 company with fiscal 1994 net sales of $1.94 billion, provides human and animal health products and specialty chemicals through its three international technology-based businesses -- Mallinckrodt Chemical and Mallinckrodt Medical, both headquartered in the St. Louis area, and Mallinckrodt Veterinary, headquartered in Mundelein, Ill. Mallinckrodt Group and its subsidiaries have 10,200 employees worldwide. Mallinckrodt Group Inc. ROGER A. KELLER Vice President, Secretary and General Counsel DATE: March 1, 1995 -----END PRIVACY-ENHANCED MESSAGE-----